155 related articles for article (PubMed ID: 31085008)
21. WIF-1 and Ihh Expression and Clinical Significance in Patients With Lung Squamous Cell Carcinoma and Adenocarcinoma.
Zhang Y; Hu C
Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):454-461. PubMed ID: 27801732
[TBL] [Abstract][Full Text] [Related]
22. FoxM1 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor metastasis.
Xu N; Jia D; Chen W; Wang H; Liu F; Ge H; Zhu X; Song Y; Zhang X; Zhang D; Ge D; Bai C
PLoS One; 2013; 8(3):e59412. PubMed ID: 23536876
[TBL] [Abstract][Full Text] [Related]
23. A gene expression signature of FOXM1 predicts the prognosis of hepatocellular carcinoma.
Song BN; Chu IS
Exp Mol Med; 2018 Jan; 50(1):e418. PubMed ID: 29303511
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of FOXM1 Is a Potential Prognostic Marker in Male Breast Cancer.
Abdeljaoued S; Bettaieb I; Nasri M; Adouni O; Goucha A; El Amine O; Boussen H; Rahal K; Gamoudi A
Oncol Res Treat; 2017; 40(4):167-172. PubMed ID: 28376490
[TBL] [Abstract][Full Text] [Related]
25. FOXM1 promotes lung adenocarcinoma invasion and metastasis by upregulating SNAIL.
Wei P; Zhang N; Wang Y; Li D; Wang L; Sun X; Shen C; Yang Y; Zhou X; Du X
Int J Biol Sci; 2015; 11(2):186-98. PubMed ID: 25561901
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological and prognostic significance of FoxM1 in gastric cancer: A meta-analysis.
Jiang D; Jiang L; Liu B; Huang H; Li W; Zhang T; Zu G; Zhang X
Int J Surg; 2017 Dec; 48():38-44. PubMed ID: 29017864
[TBL] [Abstract][Full Text] [Related]
27. A novel circular RNA, circXPO1, promotes lung adenocarcinoma progression by interacting with IGF2BP1.
Huang Q; Guo H; Wang S; Ma Y; Chen H; Li H; Li J; Li X; Yang F; Qiu M; Zhao S; Wang J
Cell Death Dis; 2020 Dec; 11(12):1031. PubMed ID: 33268793
[TBL] [Abstract][Full Text] [Related]
28. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
29. Forkhead box M1 expression in pulmonary squamous cell carcinoma: correlation with clinicopathologic features and its prognostic significance.
Yang DK; Son CH; Lee SK; Choi PJ; Lee KE; Roh MS
Hum Pathol; 2009 Apr; 40(4):464-70. PubMed ID: 19121844
[TBL] [Abstract][Full Text] [Related]
30. [Expression of FoxM1 and BCRP in invasive breast carcinoma of no special type and its prognosis significance].
Liu Y; Liu YP; Liu JY; Yang HC; Wang ZD
Zhonghua Bing Li Xue Za Zhi; 2017 Jan; 46(1):30-33. PubMed ID: 28072973
[No Abstract] [Full Text] [Related]
31. Forkhead box M1 (FOXM1) expression predicts disease free survival and may mediate resistance to chemotherapy and hormonotherapy in male breast cancer.
Abdeljaoued S; Bettaieb L; Nasri M; Adouni O; Goucha A; Bouzaiene H; Boussen H; Rahal K; Gamoudi A
Breast Dis; 2018; 37(3):109-114. PubMed ID: 29504520
[TBL] [Abstract][Full Text] [Related]
32. FOXM1: A potential indicator to predict lymphatic metastatic recurrence in stage IIA esophageal squamous cell carcinoma.
Xiao Z; Jia Y; Jiang W; Wang Z; Zhang Z; Gao Y
Thorac Cancer; 2018 Aug; 9(8):997-1004. PubMed ID: 29877046
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of forkhead box M1 (FoxM1) expression and antitumour effect of FoxM1 inhibition in melanoma.
Ito T; Kohashi K; Yamada Y; Maekawa A; Kuda M; Furue M; Oda Y
Histopathology; 2016 Jul; 69(1):63-71. PubMed ID: 26619071
[TBL] [Abstract][Full Text] [Related]
34. Expression of Tiam1 predicts lymph node metastasis and poor survival of lung adenocarcinoma patients.
Liu S; Li Y; Qi W; Zhao Y; Huang A; Sheng W; Lei B; Lin P; Zhu H; Li W; Shen H
Diagn Pathol; 2014 Mar; 9():69. PubMed ID: 24661909
[TBL] [Abstract][Full Text] [Related]
35. FOXM1 confers resistance to gefitinib in lung adenocarcinoma via a MET/AKT-dependent positive feedback loop.
Wang Y; Zhang W; Wen L; Yang H; Wen M; Yun Y; Zhao L; Zhu X; Tian L; Luo E; Li Y; Liu W; Wen N
Oncotarget; 2016 Sep; 7(37):59245-59259. PubMed ID: 27494877
[TBL] [Abstract][Full Text] [Related]
36. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031
[TBL] [Abstract][Full Text] [Related]
37. ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1.
Jiao X; Yu W; Qian J; Chen Y; Wei P; Fang W; Yu G
BMC Cancer; 2018 May; 18(1):570. PubMed ID: 29776401
[TBL] [Abstract][Full Text] [Related]
38. Clinical and Prognostic Significance of Glutathione Peroxidase 2 in Lung Adenocarcinoma.
Hashinokuchi A; Matsubara T; Ono Y; Shunichi S; Matsudo K; Nagano T; Kinoshita F; Akamine T; Kohno M; Takenaka T; Oda Y; Yoshizumi T
Ann Surg Oncol; 2024 Jul; 31(7):4822-4829. PubMed ID: 38461192
[TBL] [Abstract][Full Text] [Related]
39. IMP3 Predicts Invasion and Prognosis in Human Lung Adenocarcinoma.
Yan J; Wei Q; Jian W; Qiu B; Wen J; Liu J; Fu B; Zhou X; Zhao T
Lung; 2016 Feb; 194(1):137-46. PubMed ID: 26608347
[TBL] [Abstract][Full Text] [Related]
40. [Correlation between expression of long non-coding RNA ZXF1 and prognosis of lung adenocarcinoma and its potential molecular mechanism].
Pan GF; Zhou XF; Zhao JP
Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):102-108. PubMed ID: 28219204
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
